Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 2, 2007, Pages 94-100

  Katsutani, Masahira ^a   Ito, Takafumi ^b   Masaki, Takao ^a   Kohno, Nobuoki ^a   Yorioka, Noriaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

ERK1 2; Human peritoneal mesothelial cell; Icodextrin; PAI 1; PD solution; t PA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DIALYSIS FLUID; GLUCOSE; ICODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSMOTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROGENESIS; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PERITONEAL DIALYSIS; PERITONEUM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

CELLS, CULTURED; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; EPITHELIUM; FLAVONOIDS; GLUCANS; GLUCOSE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PERITONEAL DIALYSIS; PERITONEUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33947401012     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00423.x     Document Type: Article

References (25)

1. Sitter T, Spannag M, Schiffi H, Held E, van Hinsbergh VWM, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995;10:677-83.
2. Shao JC, Yorioka N, Nishida Y, Yamakido M. Effect of pH and glucose on cultured human peritoneal mesothelial cells. Scand J Urol Nephrol 1999;33:248-56.
3. Sitter T, Mandl-Weber S, Wornle M, Haslinger B, Goedde M, Kooistra T. D-glucose increases the synthesis of tissue-type plasminogen activator (t-PA) in human peritoneal mesothelial cells. Thromb Haemost 1999;82:1171-6.
4. Sitter T, Toet K, Fricke H, Schffi H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 1996;271:R1256-63.
5. Geoddle M, Sitter T, Schiffl H, Bechtel U, Schramm W, Spannagl M. Coagulation- and fibrinolysis- related antigens in plasma and dialysate of CAPD patients. Perit Dial Int 1997;17:121-4.
6. Zhang PL, Takahara T, Yata Y et al. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of satellite cells. J Hepatol 1999;31:703-11.
7. Olman MA, Mackman N, Gladson CL, Moser KM, Loskutoff DJ. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 1995;96:1621-30.
8. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 1999;7:147-59.
9. Oda T, Jung GO, Kim HS et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 2001;30:587-96.
10. Higuchi C, Tanihata Y, Nishimura H, Naito T, Sanaka T. Effects of glucose and Plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum. Ther Apher Dial 2005;9:173-81.
11. Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T. Transforming growth factor-β1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an upregulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem 2003;278:26793-802.
12. Sitter T, Haslinger B, Mandl S, Fricke H, Held E, Sellmayer A. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity. JAm Soc Nephrol 1998;9:2005-12.
13. Thomas S, Schnek U, Fischer FP, Mettang T, Passlick-Deetjen J, Kuhlmann U. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. Am J Kidney Dis 1997;29:246-53.
14. Ito T, Yorioka N, Kyuden Y et al. Effect of glucose polymer on the intracellular junctions of cultured human peritoneal membrane. Nephron Clin Pract 2003;93:c97-105.
15. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563-70.
16. Ito T, Yorioka N, Yamamoto M, Kataoka K, Yamakido M. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000;11:1969-79.
17. Kiribayashi K, Masaki T, Naito T et al. Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int 2005;67:1126-35.
18. Suzuki M, Akimoto K, Hattori Y. Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells. Life Sci 2002;72:59-66.
19. Fujita H, Omori S, Ishikura K, Hida M, Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells. Am J Physiol Renal Physiol 2004;286:F120-6.
20. Haslinger B, Mandl-Weber S, Sellmayer A, Lederer SR, Sitter T. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C. Nephron 2001;87:346-51.
21. Matsuo S, Lopez-Guisa JM, Cai X et al. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int 2005;67:2221-38.
22. Hung Y, Noble N. An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis. Kidney Int 2005;67:2502-3.
23. Yang J, Shultz RW, Mars WM et al. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002;110:1525-38.
24. Edgtton KL, Gow RM, Kelly DJ, Carmeliet P, Kitching RA. Plasmin is not protective in experimental renal interstitial fibrosis. Kidney Int 2004;66:68-76.
25. Sitter T, Toet K, Quax P, Kooistra T. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Kidney Int 1999;55:120-9.